On the other hand, the phosphorylation of ERK (p < 0.01), JNK (p < 0.05), and p38 (p < 0.01) in the BPH + Igsu group showed a significant reduction compared to the BPH group. Here, MAPK14 is linked to benign prostatic hyperplasia.